BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 33923431)

  • 1. PCSK9 Induces Rat Smooth Muscle Cell Proliferation and Counteracts the Pleiotropic Effects of Simvastatin.
    Lupo MG; Marchianò S; Adorni MP; Zimetti F; Ruscica M; Greco MF; Corsini A; Ferri N
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33923431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Triggers Vascular Smooth Muscle Cell Senescence and Apoptosis: Implication of Its Direct Role in Degenerative Vascular Disease.
    Guo Y; Tang Z; Yan B; Yin H; Tai S; Peng J; Cui Y; Gui Y; Belke D; Zhou S; Zheng XL
    Arterioscler Thromb Vasc Biol; 2022 Jan; 42(1):67-86. PubMed ID: 34809446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PCSK9 knock-out mice are protected from neointimal formation in response to perivascular carotid collar placement.
    Ferri N; Marchianò S; Tibolla G; Baetta R; Dhyani A; Ruscica M; Uboldi P; Catapano AL; Corsini A
    Atherosclerosis; 2016 Oct; 253():214-224. PubMed ID: 27477186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proprotein convertase subtilisin kexin type 9 (PCSK9) secreted by cultured smooth muscle cells reduces macrophages LDLR levels.
    Ferri N; Tibolla G; Pirillo A; Cipollone F; Mezzetti A; Pacia S; Corsini A; Catapano AL
    Atherosclerosis; 2012 Feb; 220(2):381-6. PubMed ID: 22176652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Geranylgeraniol prevents the simvastatin-induced PCSK9 expression: Role of the small G protein Rac1.
    Ferri N; Marchianò S; Lupo MG; Trenti A; Biondo G; Castaldello P; Corsini A
    Pharmacol Res; 2017 Aug; 122():96-104. PubMed ID: 28554582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitosan oligosaccharides enhance lipid droplets via down-regulation of PCSK9 gene expression in HepG2 cells.
    Yang X; Zhang J; Chen L; Wu Q; Yu C
    Exp Cell Res; 2018 May; 366(2):152-160. PubMed ID: 29548750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of PCSK9 by nutraceuticals.
    Momtazi AA; Banach M; Pirro M; Katsiki N; Sahebkar A
    Pharmacol Res; 2017 Jun; 120():157-169. PubMed ID: 28363723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of Adiponectin Receptor Regulates Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Inhibits Lesions in ApoE-Deficient Mice.
    Sun L; Yang X; Li Q; Zeng P; Liu Y; Liu L; Chen Y; Yu M; Ma C; Li X; Li Y; Zhang R; Zhu Y; Miao QR; Han J; Duan Y
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1290-1300. PubMed ID: 28546220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclase-associated protein 1 is a binding partner of proprotein convertase subtilisin/kexin type-9 and is required for the degradation of low-density lipoprotein receptors by proprotein convertase subtilisin/kexin type-9.
    Jang HD; Lee SE; Yang J; Lee HC; Shin D; Lee H; Lee J; Jin S; Kim S; Lee SJ; You J; Park HW; Nam KY; Lee SH; Park SW; Kim JS; Kim SY; Kwon YW; Kwak SH; Yang HM; Kim HS
    Eur Heart J; 2020 Jan; 41(2):239-252. PubMed ID: 31419281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PCSK9 and atherosclerosis: Looking beyond LDL regulation.
    Ragusa R; Basta G; Neglia D; De Caterina R; Del Turco S; Caselli C
    Eur J Clin Invest; 2021 Apr; 51(4):e13459. PubMed ID: 33236356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Cholesterol-Modulating Effect of Methanol Extract of Pigeon Pea (
    Chang HY; Wu JR; Gao WY; Lin HR; Chen PY; Chen CI; Wu MJ; Yen JH
    Molecules; 2019 Jan; 24(3):. PubMed ID: 30704067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lunasin Improves the LDL-C Lowering Efficacy of Simvastatin via Inhibiting PCSK9 Expression in Hepatocytes and ApoE
    Gu L; Gong Y; Zhao C; Wang Y; Tian Q; Lei G; Liang Y; Zhao W; Tan S
    Molecules; 2019 Nov; 24(22):. PubMed ID: 31731717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PCSK9 promotes arterial medial calcification.
    Lupo MG; Bressan A; Donato M; Canzano P; Camera M; Poggio P; Greco MF; Garofalo M; De Martin S; Panighel G; Ruscica M; Baragetti A; Bollati V; Faggin E; Rattazzi M; Catapano AL; Ferri N
    Atherosclerosis; 2022 Apr; 346():86-97. PubMed ID: 35135698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-Talk Between PCSK9 and Damaged mtDNA in Vascular Smooth Muscle Cells: Role in Apoptosis.
    Ding Z; Liu S; Wang X; Mathur P; Dai Y; Theus S; Deng X; Fan Y; Mehta JL
    Antioxid Redox Signal; 2016 Dec; 25(18):997-1008. PubMed ID: 27197615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the proprotein convertase subtilisin/kexin type 9 for the treatment of dyslipidemia and atherosclerosis.
    Urban D; Pöss J; Böhm M; Laufs U
    J Am Coll Cardiol; 2013 Oct; 62(16):1401-8. PubMed ID: 23973703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory mechanism of mineral-balanced deep sea water on hypocholesterolemic effects in HepG2 hepatic cells.
    Lee KS; Kwon YS; Kim S; Moon DS; Kim HJ; Nam KS
    Biomed Pharmacother; 2017 Feb; 86():405-413. PubMed ID: 28012395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic overexpression of idol increases circulating protein convertase subtilisin/kexin type 9 in mice and hamsters via dual mechanisms: sterol regulatory element-binding protein 2 and low-density lipoprotein receptor-dependent pathways.
    Sasaki M; Terao Y; Ayaori M; Uto-Kondo H; Iizuka M; Yogo M; Hagisawa K; Takiguchi S; Yakushiji E; Nakaya K; Ogura M; Komatsu T; Ikewaki K
    Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1171-8. PubMed ID: 24675665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Single Domain Antibodies Are Potent Inhibitors of Low Density Lipoprotein Receptor Degradation.
    Weider E; Susan-Resiga D; Essalmani R; Hamelin J; Asselin MC; Nimesh S; Ashraf Y; Wycoff KL; Zhang J; Prat A; Seidah NG
    J Biol Chem; 2016 Aug; 291(32):16659-71. PubMed ID: 27284008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alginate oligosaccharide enhances LDL uptake via regulation of LDLR and PCSK9 expression.
    Yang JH; Bang MA; Jang CH; Jo GH; Jung SK; Ki SH
    J Nutr Biochem; 2015 Nov; 26(11):1393-400. PubMed ID: 26320675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proprotein Convertase Subtilisin Kexin Type 9 Inhibition for Autosomal Recessive Hypercholesterolemia-Brief Report.
    Thedrez A; Sjouke B; Passard M; Prampart-Fauvet S; Guédon A; Croyal M; Dallinga-Thie G; Peter J; Blom D; Ciccarese M; Cefalù AB; Pisciotta L; Santos RD; Averna M; Raal F; Pintus P; Cossu M; Hovingh K; Lambert G
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1647-50. PubMed ID: 27079874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.